Asia-Pacific Journal of Clinical Oncology

Aims & Scope

Asia–Pacific Journal of Clinical Oncology is a multidisciplinary journal of oncology that aims to be a forum for facilitating collaboration and exchanging information on what is happening in different countries of the Asia–Pacific region in relation to cancer treatment and care.

The Journal is ideally positioned to receive publications that deal with diversity in cancer behavior, management and outcome related to ethnic, cultural, economic and other differences between populations.

In addition to original articles, the Journal publishes reviews, editorials, letters to the Editor and short communications.

Case reports are generally not considered for publication, only exceptional papers in which Editors find extraordinary oncological value may be considered for review.

The Journal encourages clinical studies, particularly prospectively designed clinical trials.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.6
2024	1.40

SJR (SCImago Journal Rank)

Year	Value
2024	0.570

Quartile

Year	Value
2024	Q2

Journal Rank

Year	Value
2024	10202

Journal Citation Indicator

Year	Value
2024	637

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Epidemiology of breast cancer in Indian women

  Citation: 500

  Authors: Shreshtha, Sarangadhara Appalaraju, Uma S., Sunita

• Health state utilities in non–small cell lung cancer: An international study

  Citation: 233

  Authors: Beenish, Andrew J, Sarah, Narayan, Maria

• MG132, a proteasome inhibitor, induces apoptosis in tumor cells

  Citation: 181

  Authors: Na, Zhilan

• Identifying the most prevalent unmet needs of cancer survivors in Australia: A systematic review

  Citation: 146

  Authors: Karolina, Laura, Amanda, Michael

• Biomarkers and therapeutic advances in glioblastoma multiforme

  Citation: 138

  Authors: Andrew Octavian, Ying Pei, Anna Pick Kiong

• Importance of health literacy in oncology

  Citation: 111

  Authors: Kelvin, Penelope, Michael

• Metastatic triple negative breast cancer: Optimizing treatment options, new and emerging targeted therapies

  Citation: 92

  Authors: Parham, Luis, Sara

• Role and mechanism of autophagy‐regulating factors in tumorigenesis and drug resistance

  Citation: 89

  Authors: Rana Muhammad, Faryal, Arshia, Arafat Ali, Ahmad, Azka, Hamza, Jianjun, Jennifer S., Steffan T., Faiz

• Exosomal tetraspanins as regulators of cancer progression and metastasis and novel diagnostic markers

  Citation: 88

  Authors: Rama Rao, Santhi, Seema, Murali Mohan, Anil Kumar

• End‐of‐life care: Where do cancer patients want to die? A systematic review

  Citation: 87

  Authors: Jonas, Carl, Georg, Tobias, Michael, Stefan

---